AskBio CEO and Co-Founder Sheila Mikhail receives 2022 Entrepreneurial Award from University of Chicago Booth School of Business

Prestigious recognition for excellent professional achievement in the formation of a prosperous organization awarded to Booth School of Business enterprise Alumni

Exploration TRIANGLE PARK, N.C., June 3, 2022 /PRNewswire/ — Asklepios BioPharmaceutical, Inc. (AskBio), an independently operated subsidiary of Bayer AG, these days announced that CEO and Co-Founder Sheila Mikhail was recognized by the College of Chicago Booth University of Company for remarkable skilled accomplishment between its alumni. As a 1993 finance MBA graduate with honors, Ms. Mikhail has been recognized with the 2022 Entrepreneurial Award.

“This award is greatly meaningful as the Booth School of Organization is 1 of the nation’s prime ranked organization educational institutions,” mentioned AskBio Co-Founder and CEO Sheila Mikhail. “The award is a reflection of the accomplishments that could not be achievable without having the support of a world-class workforce at AskBio as we continue on to progress our analysis, scientific candidates and production abilities.”

Ms. Mikhail attained a JD with honors from Northwestern College, a finance MBA with honors from the University of Chicago, and a BS with optimum honors from the College of Illinois at Urbana-Champaign. She co-launched AskBio in 2001 with Dr. R. Jude Samulski, who is thought of one particular of the top pioneers for AAV gene remedy technologies.  Because co-founding AskBio, and beneath the management of Ms. Mikhail, the corporation, together with its production services, has developed to hire above 700 biotech industry experts working in five international locations.

Eighteen months following closing a series A funding spherical of $235 million in April 2019, Ms. Mikhail orchestrated a $4 billion acquisition by Bayer AG in Oct 2020.  Below Ms. Mikhail’s leadership, AskBio is flourishing with an expansive gene remedy technological know-how toolbox, 3 state-of-the-art manufacturing facilities in San Sebastian Spain and a strong therapeutic pipeline, all at several medical levels, to take care of Pompe Disorder, Limbe Girdle Muscular Dystrophy, Several Technique Atrophy, Congestive Heart Failure, Huntington’s Disease, and Parkinson’s Disorder.

“In my see, Sheila is one particular of the most attained Biotech executives in the business,” commented Dr. Samulski, AskBio’s Co-Founder and Main Scientific Officer. “The recognition by University of Chicago Booth Faculty of Company is a testament of her unparalleled small business acumen blended with her important command of genetic science”

The Distinguished Alumni awards are only available to graduates of Chicago Booth. The Entrepreneurial Award is provided to a person who has demonstrated qualified achievement of the highest caliber in the administration and formation of a profitable company and is recognition by colleagues and peers for remarkable management and administrative qualities.

About AskBio

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG obtained in 2020, is a thoroughly integrated gene treatment enterprise focused to producing lifetime-preserving medicines that overcome genetic diseases. The firm maintains a portfolio of scientific packages across a selection of neuromuscular, central nervous procedure, cardiovascular and metabolic ailment indications with a clinical-stage pipeline that incorporates therapeutics for Pompe ailment, Parkinson’s ailment, and congestive coronary heart failure. AskBio’s gene therapy platform contains Professional10™, an sector-major proprietary cell line producing method, and an extensive capsid and promoter library. With world headquarters in Study Triangle Park, North Carolina, and European headquarters in Edinburgh, United kingdom, the organization has generated hundreds of proprietary capsids and promoters, numerous of which have entered scientific testing. Founded in 2001 and an early innovator in the gene treatment subject, the enterprise retains a lot more than 750 patents in spots these kinds of as AAV creation and chimeric and self-complementary capsids. Study much more at www.askbio.com or adhere to us on LinkedIn. 

About Bayer

Bayer is a international enterprise with main competencies in the daily life science fields of health and fitness care and diet. Its products and solutions and providers are designed to enable people and the world prosper by supporting attempts to master the key troubles offered by a escalating and aging worldwide populace. Bayer is fully commited to driving sustainable improvement and producing a constructive impression with its enterprises. At the similar time, the Group aims to enhance its earning energy and build value by way of innovation and development. The Bayer manufacturer stands for rely on, reliability, and top quality all through the entire world. In fiscal 2021, the Group utilized around 100,000 people today and had sales of 44.1 billion euros. R&D expenditures right before specific things amounted to 5.3 billion euros. For more information and facts, visit www.bayer.com. 

AskBio Forward-Searching Statements

This press launch consists of “ahead-seeking statements.” Any statements contained in this press release that are not statements of historical reality may well be deemed to be forward-seeking statements. Text these types of as “thinks,” “anticipates,” “strategies,” “expects,” “will,” “intends,” “probable,” “feasible” and very similar expressions are intended to detect forward-wanting statements. These ahead-searching statements include without limitation statements with regards to AskBio’s pipeline of enhancement candidates, manufacturing technologies and procedure. These ahead-searching statements entail threats and uncertainties, lots of of which are past AskBio’s regulate. Identified hazards incorporate, among the some others: AskBio may possibly not be capable to execute on its small business ideas and goals, which includes conference its predicted or prepared regulatory milestones and timelines, its reliance on 3rd-events, medical advancement options, producing procedures and designs, and bringing its merchandise candidates to current market, thanks to a wide range of good reasons, like the ongoing COVID-19 pandemic, feasible limitations of enterprise fiscal and other resources, producing constraints that may not be predicted or fixed in a timely way, potential disagreements or other challenges with our third-party collaborators and partners, and regulatory, court docket or company opinions or selections, this kind of as feedback and choices from the United States Food items and Drug Administration or the United States Patent and Trademark Place of work. Any of the foregoing risks could materially and adversely have an effect on AskBio’s enterprise and final results of operations. You ought to not location undue reliance on the ahead-looking statements contained in this press release. AskBio does not undertake any obligation to publicly update its ahead-looking statements based on situations or circumstances just after the day hereof. 

Perspective initial content to down load multimedia:https://www.prnewswire.com/news-releases/askbio-ceo-and-co-founder-sheila-mikhail-receives-2022-entrepreneurial-award-from-college-of-chicago-booth-college-of-company-301560981.html

Supply AskBio